-
Je něco špatně v tomto záznamu ?
Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space
M. Maly, T. Riedel, J. Stikarova, J. Suttnar, R. Kotlin, M. Hajsl, P. Tousek, J. Kaufmanova, O. Kucerka, JW. Weisel, JE. Dyr
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
Ministry of Health, Czech Republic
00023736
Czech Science Foundation
P205/12/G118
European Regional Development Fund and the state budget of the Czech Republic
CZ.02.1.01/0.0/0.0/16_025/0007428
National Institutes of Health grant
HL148227
PubMed
34781375
DOI
10.1055/s-0041-1739193
Knihovny.cz E-zdroje
- MeSH
- čas zasáhnout při rozvinutí nemoci MeSH
- časové faktory MeSH
- erytrocyty patologie MeSH
- fibrin analýza MeSH
- fibrinolytika * aplikace a dávkování škodlivé účinky MeSH
- hemokoagulace účinky léků fyziologie MeSH
- infarkt myokardu s elevacemi ST úseků * etiologie terapie MeSH
- koronární trombóza * diagnostické zobrazování farmakoterapie metabolismus patologie MeSH
- léková rezistence fyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikroskopie elektronová rastrovací metody MeSH
- trombektomie metody MeSH
- trombocyty patologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
We describe the internal structure, spatial organization and dynamic formation of coronary artery thrombi from ST-segment elevation myocardial infarction patients. Scanning electron microscopy (SEM) revealed significant differences among four groups of patients (<2 hours; 2-6 hours; 6-12 hours, and >12 hours) related to the time of ischemia. Coronary artery thrombi from patients presenting less than 2 hours after the infarction were almost entirely composed of platelets, with small amounts of fibrin and red blood cells. In contrast, thrombi from late presenters (>12 hours) consisted of mainly platelets at the distal end, where clotting was initiated, with almost no platelets at the proximal end, while the red blood cell content went from low at the initiating end to more than 90% at the proximal end. Furthermore, fibrin was present mainly on the outside of the thrombi and older thrombi contained thicker fibers. The red blood cells in late thrombi were compressed to a close-packed, tessellated array of polyhedral structures, called polyhedrocytes. Moreover, there was redistribution from the originally homogeneous composition to fibrin and platelets to the outside, with polyhedrocytes on the interior. The presence of polyhedrocytes and the redistribution of components are signs of in vivo clot contraction (or retraction). These results suggest why later thrombi are resistant to fibrinolytic agents and other treatment modalities, since the close-packed polyhedrocytes form a nearly impermeable seal. Furthermore, it is of particular clinical significance that these findings suggest specific disparate therapies that will be most effective at different stages of thrombus development.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010923
- 003
- CZ-PrNML
- 005
- 20220506130210.0
- 007
- ta
- 008
- 220425s2022 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/s-0041-1739193 $2 doi
- 035 __
- $a (PubMed)34781375
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Maly, Martin $u First Faculty of Medicine, Department of Medicine, Charles University in Prague and Military University Hospital, Prague, Czech Republic
- 245 10
- $a Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space / $c M. Maly, T. Riedel, J. Stikarova, J. Suttnar, R. Kotlin, M. Hajsl, P. Tousek, J. Kaufmanova, O. Kucerka, JW. Weisel, JE. Dyr
- 520 9_
- $a We describe the internal structure, spatial organization and dynamic formation of coronary artery thrombi from ST-segment elevation myocardial infarction patients. Scanning electron microscopy (SEM) revealed significant differences among four groups of patients (<2 hours; 2-6 hours; 6-12 hours, and >12 hours) related to the time of ischemia. Coronary artery thrombi from patients presenting less than 2 hours after the infarction were almost entirely composed of platelets, with small amounts of fibrin and red blood cells. In contrast, thrombi from late presenters (>12 hours) consisted of mainly platelets at the distal end, where clotting was initiated, with almost no platelets at the proximal end, while the red blood cell content went from low at the initiating end to more than 90% at the proximal end. Furthermore, fibrin was present mainly on the outside of the thrombi and older thrombi contained thicker fibers. The red blood cells in late thrombi were compressed to a close-packed, tessellated array of polyhedral structures, called polyhedrocytes. Moreover, there was redistribution from the originally homogeneous composition to fibrin and platelets to the outside, with polyhedrocytes on the interior. The presence of polyhedrocytes and the redistribution of components are signs of in vivo clot contraction (or retraction). These results suggest why later thrombi are resistant to fibrinolytic agents and other treatment modalities, since the close-packed polyhedrocytes form a nearly impermeable seal. Furthermore, it is of particular clinical significance that these findings suggest specific disparate therapies that will be most effective at different stages of thrombus development.
- 650 _2
- $a hemokoagulace $x účinky léků $x fyziologie $7 D001777
- 650 _2
- $a trombocyty $x patologie $7 D001792
- 650 12
- $a koronární trombóza $x diagnostické zobrazování $x farmakoterapie $x metabolismus $x patologie $7 D003328
- 650 _2
- $a léková rezistence $x fyziologie $7 D004351
- 650 _2
- $a erytrocyty $x patologie $7 D004912
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibrin $x analýza $7 D005337
- 650 12
- $a fibrinolytika $x aplikace a dávkování $x škodlivé účinky $7 D005343
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikroskopie elektronová rastrovací $x metody $7 D008855
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a infarkt myokardu s elevacemi ST úseků $x etiologie $x terapie $7 D000072657
- 650 _2
- $a trombektomie $x metody $7 D017131
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a čas zasáhnout při rozvinutí nemoci $7 D061665
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Riedel, Tomas $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Stikarova, Jana $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000259640526
- 700 1_
- $a Suttnar, Jiri $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Kotlin, Roman $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Hajsl, Martin $u First Faculty of Medicine, Department of Medicine, Charles University in Prague and Military University Hospital, Prague, Czech Republic
- 700 1_
- $a Tousek, Petr $u Cardiocenter, University Hospital Kralovske Vinohrady and Third Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a Kaufmanova, Jirina $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Prague, Czech Republic
- 700 1_
- $a Kucerka, Ondrej $u First Faculty of Medicine, Department of Medicine, Charles University in Prague and Military University Hospital, Prague, Czech Republic
- 700 1_
- $a Weisel, John W $u Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
- 700 1_
- $a Dyr, Jan E $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 773 0_
- $w MED00004517 $t Thrombosis and haemostasis $x 2567-689X $g Roč. 122, č. 3 (2022), s. 434-444
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34781375 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130202 $b ABA008
- 999 __
- $a ok $b bmc $g 1788846 $s 1162121
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 122 $c 3 $d 434-444 $e 20211115 $i 2567-689X $m Thrombosis and haemostasis $n Thromb Haemost $x MED00004517
- GRA __
- $a Ministry of Health, Czech Republic $p 00023736
- GRA __
- $a Czech Science Foundation $p P205/12/G118
- GRA __
- $a European Regional Development Fund and the state budget of the Czech Republic $p CZ.02.1.01/0.0/0.0/16_025/0007428
- GRA __
- $a National Institutes of Health grant $p HL148227
- LZP __
- $a Pubmed-20220425